Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease
Joana A. Loureiro, Stéphanie Andrade, Ana Amélia Machado Duarte, et al.
Molecules (2017) Vol. 22, Iss. 2, pp. 277-277
Open Access | Times Cited: 279

Showing 1-25 of 279 citing articles:

Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms
Haseeb Anwar Dad, Ting-Wei Gu, Ao-Qing Zhu, et al.
Molecular Therapy (2020) Vol. 29, Iss. 1, pp. 13-31
Open Access | Times Cited: 397
Alzheimer’s disease and its treatment by different approaches: A review
Sukriti Srivastava, Razi Ahmad, Sunil Kumar Khare
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113320-113320
Closed Access | Times Cited: 343
Gut microbial molecules in behavioural and neurodegenerative conditions
Brittany D. Needham, Rima Kaddurah‐Daouk, Sarkis K. Mazmanian
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 12, pp. 717-731
Closed Access | Times Cited: 276
Towards Improvements for Penetrating the Blood–Brain Barrier—Recent Progress from a Material and Pharmaceutical Perspective
Quanguo He, Jun Liu, Jing Liang, et al.
Cells (2018) Vol. 7, Iss. 4, pp. 24-24
Open Access | Times Cited: 262
Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals
David Julian McClements
Biotechnology Advances (2018) Vol. 38, pp. 107287-107287
Open Access | Times Cited: 254
Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stéphanie Andrade, Maria João Ramalho, Joana A. Loureiro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2313-2313
Open Access | Times Cited: 201
Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines
Chunhua Yang, Mingzhen Zhang, Didier Merlin
Journal of Materials Chemistry B (2018) Vol. 6, Iss. 9, pp. 1312-1321
Open Access | Times Cited: 196
Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease
Govindarajan Karthivashan, Palanivel Ganesan, Shin‐Young Park, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 307-320
Open Access | Times Cited: 194
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Mantosh Kumar Satapathy, Ting‐Lin Yen, Jing‐Shiun Jan, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1183-1183
Open Access | Times Cited: 180
Nanodelivery of Natural Antioxidants: An Anti-aging Perspective
Alexander Vaiserman, Alexander Koliada, Alina Zayachkivska, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 7
Open Access | Times Cited: 167
Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives
Sumaira Anjum, Sara Ishaque, Hijab Fatima, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 707-707
Open Access | Times Cited: 164
Neuroprotective Natural Products for Alzheimer’s Disease
Xin Chen, Joshua Adam Drew, Wren Berney, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1309-1309
Open Access | Times Cited: 152
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease
Rúben G. R. Pinheiro, Andreia Granja, Joana A. Loureiro, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 148, pp. 105314-105314
Closed Access | Times Cited: 144
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 139
Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 137
Surface Modification of Lipid-Based Nanoparticles
Yining Xu, Thibaut Fourniols, Yasmine Labrak, et al.
ACS Nano (2022) Vol. 16, Iss. 5, pp. 7168-7196
Closed Access | Times Cited: 111
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
Aline de Alcântara Correia, Ana Rita Monteiro, RAYANNA BEATRIZ MARQUES DA SILVA, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114485-114485
Closed Access | Times Cited: 103
Polyphenols in Metabolic Diseases
Amin Gasmi, Pavan Kumar Mujawdiya, Sàdaf Noor, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6280-6280
Open Access | Times Cited: 101
Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development
Izabela Grabska-Kobyłecka, Piotr Szpakowski, Aleksandra Król, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3454-3454
Open Access | Times Cited: 94
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 75
Plant-Derived Exosome-Like Nanovesicles: Current Progress and Prospects
Nai Mu, Jie Li, Li Zeng, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4987-5009
Open Access | Times Cited: 75
Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
Attilio Marino, Matteo Battaglini, Nadia Moles, et al.
ACS Omega (2022) Vol. 7, Iss. 30, pp. 25974-25990
Open Access | Times Cited: 72
Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development
Hamdoon A. Mohammed, Riaz Khan, Varsha Singh, et al.
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis
Yuyi Xu, Ming Zhao, Jinxue Cao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4417-4441
Open Access | Times Cited: 46
By-Products as Sustainable Source of Bioactive Compounds for Potential Application in the Field of Food and New Materials for Packaging Development
Edmondo Messinese, Olimpia Pitirollo, Maria Grazia Grimaldi, et al.
Food and Bioprocess Technology (2023) Vol. 17, Iss. 3, pp. 606-627
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top